BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16822421)

  • 1. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Hodgkin's lymphoma in Scandinavia.
    Jønsson V; Awan H; Nyquist E; Maisenhølder M; Johannesen TB; Ly B; Tjønnfjord GE
    In Vivo; 2011; 25(3):431-7. PubMed ID: 21576419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].
    Jakó J; Szerafin L; Póth I; Nagy P; Smanykó D; Babicz T
    Orv Hetil; 1992 Jan; 133(3):147-8, 153. PubMed ID: 1734343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
    Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
    Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Health databases to assess the incidence of lymphoid malignancies in Italian population].
    Borciani N; Vinceti M; Avanzini P; Ilariucci F; Mangone L; Martini M; Merlin M; Ferretti A; Frassineti M; Rodolfi R; Bergomi M
    Epidemiol Prev; 2000; 24(2):81-4. PubMed ID: 10863849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of neoplasms of the hematopoietic and lymphoreticular systems in the Lower Silesia. III. Neoplasms of the lymphoreticular system in various provinces].
    Kin-Dittmann I; Kotlarek-Haus S; Waszkiewicz L; Kuriata E
    Acta Haematol Pol; 1991; 22(2):251-60. PubMed ID: 1841496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte esterase? A factor involved in the pathogenesis of lymphoproliferative neoplasia.
    Markey GM; Morris TC; Alexander HD; Kyle A; Middleton D; Turner A; Burnside P; Drexler HG; Gaedicke G; Hartmen W
    Leukemia; 1987 Mar; 1(3):236-9. PubMed ID: 3669745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
    Altieri A; Bermejo JL; Hemminki K
    Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology.
    Altieri A; Castro F; Bermejo JL; Hemminki K
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1281-6. PubMed ID: 16835324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
    Goldin LR; Caporaso NE
    Br J Haematol; 2007 Dec; 139(5):774-9. PubMed ID: 18021091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferative and myeloproliferative disease in Tasmania.
    Lickiss JN; Baikie AG; Panton J
    Natl Cancer Inst Monogr; 1977 Dec; 47():37-9. PubMed ID: 613244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aging of the population and incidence of primary acquired hemopathies in the Autonomous Community of Aragón].
    Giraldo Castellano P; Franco García E; Bernal Pérez M; Huelin Domeco de Jarauta J; Rubio-Félix D; Giralt Raichs M
    Rev Esp Salud Publica; 1998; 72(6):559-70. PubMed ID: 10050606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
    Brown JR; Neuberg D; Phillips K; Reynolds H; Silverstein J; Clark JC; Ash M; Thompson C; Fisher DC; Jacobsen E; LaCasce AS; Freedman AS
    Br J Haematol; 2008 Nov; 143(3):361-8. PubMed ID: 18729853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigenaemia in patients with malignant lymphoproliferative disorders.
    Olatunji PO; Okpala IE; Sorunmu MA
    Tokai J Exp Clin Med; 1991 Oct; 16(3-4):171-3. PubMed ID: 1811350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial occurrence of chronic lymphocytic leukaemia in Norway.
    Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB
    Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial chronic lymphocytic leukemia.
    Sellick GS; Catovsky D; Houlston RS
    Semin Oncol; 2006 Apr; 33(2):195-201. PubMed ID: 16616066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lympho-hemopoietic malignancies in India.
    Bhutani M; Vora A; Kumar L; Kochupillai V
    Med Oncol; 2002; 19(3):141-50. PubMed ID: 12482124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.